Florence, Italy, 12 March 2018 – The 17,000th employee in MENARINI is Lara, 28 years old, a young graduate in Chemistry and Pharmaceutical Technology from the University of Florence, who is now employed in MENARINI Ricerche.

MENARINI is present in 136 countries world-wide and continues to invest heavily in Italy: out of 17,000 Group employees, more than 3,700 work in Italy, almost 300 of whom hired over the last two years and work in the Group’s Florentine headquarters. With an average age of 29, they are all highly qualified profiles and more than 90% of MENARINI employees hold a degree or technical diploma.

"We are proud of this achievement- said Lucia Aleotti and Alberto Giovanni Aleotti, Chairman and Vice Chairman of the MENARINI Group - and take this opportunity to highlight how being able to hire the 17,000th staff member is largely due to the extraordinary work carried out by all our employees who, with enthusiasm and determination, are the true makers of the success of the Menarini Group".

With the opening of two new affiliates in Peru and Colombia, investments in the Berlin and Pisa research centers, and the growth of Asia Pacific, MENARINI's strategy has always been focused on both the quality of their products and internationalization. MENARINI closed the year 2017 with a turnover of 3.6 billion Euro.
 

About the MENARINI Group

The MENARINI Group, with its headquarters in Florence, is present in 136 countries around the world with 17,000 employees. With a turnover of 3.6 billion Euro, MENARINI today is 13th in Europe out of 5.345 companies and 35th worldwide out of 21,587 (source: IQVIA). MENARINI has 6 Research & Development centres and its products are present in the most important therapeutic areas including cardiology, gastroenterology, pneumology, infectious diseases, diabetology, anti-inflammatory agents, and analgesics. MENARINI's products are manufactured in the Group's 16 production sites, in Italy and abroad, where more than 583 million packs are produced and distributed over five continents each year. Through its pharmaceutical products, MENARINI contributes continuously and with the highest quality standards towards the health of patients all around the world. For further information:  www.menarini.com